Sumati Gupta

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial

Toni K. Choueiri, James Larkin, Mototsugu Oya et al. · The Lancet Oncology · 2018 · 260 citations

Medicine, Oncology, Pharmacology +10

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> Alterations

Sumanta K. Pal, Jonathan E. Rosenberg, Jean Hoffman‐Censits et al. · Cancer Discovery · 2018 · 257 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021

Efrat Dotan, Louise C. Walter, Ilene Browner et al. · Journal of the National Comprehensive Cancer Network · 2021 · 197 citations · Full text

Medicine, Geriatric Medicine, Oncology +13

Complicated grief and deficits in emotional expressive flexibility.

Sumati Gupta, George A. Bonanno · Journal of Abnormal Psychology · 2011 · 168 citations

Social Sciences, Behavioral Sciences, Psychology +12